Essential psychopharmacology of antipsychotics and mood stabilizers:
Gespeichert in:
1. Verfasser: | |
---|---|
Format: | Buch |
Sprache: | English |
Veröffentlicht: |
Cambridge
Cambridge Univ. Pr.
2002
|
Schlagworte: | |
Online-Zugang: | Publisher description Table of contents Inhaltsverzeichnis |
Beschreibung: | Includes bibliographical references (p. 133-136) and index |
Beschreibung: | IX, 142 S. Ill., graph. Darst. |
ISBN: | 0521890748 |
Internformat
MARC
LEADER | 00000nam a2200000zc 4500 | ||
---|---|---|---|
001 | BV014438746 | ||
003 | DE-604 | ||
005 | 20020903 | ||
007 | t | ||
008 | 020603s2002 xxkad|| |||| 00||| eng d | ||
010 | |a 2002023355 | ||
020 | |a 0521890748 |9 0-521-89074-8 | ||
035 | |a (OCoLC)49376212 | ||
035 | |a (DE-599)BVBBV014438746 | ||
040 | |a DE-604 |b ger |e aacr | ||
041 | 0 | |a eng | |
044 | |a xxk |c GB | ||
049 | |a DE-29 | ||
050 | 0 | |a RM333.5 | |
082 | 0 | |a 615/.788 |2 21 | |
100 | 1 | |a Stahl, Stephen M. |d 1951- |e Verfasser |0 (DE-588)136518257 |4 aut | |
245 | 1 | 0 | |a Essential psychopharmacology of antipsychotics and mood stabilizers |c Stephen M. Stahl |
264 | 1 | |a Cambridge |b Cambridge Univ. Pr. |c 2002 | |
300 | |a IX, 142 S. |b Ill., graph. Darst. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
500 | |a Includes bibliographical references (p. 133-136) and index | ||
650 | 7 | |a Antipsychotische geneesmiddelen |2 gtt | |
650 | 7 | |a Psychosen |2 gtt | |
650 | 7 | |a Schizofrenie |2 gtt | |
650 | 4 | |a Antipsychotic Agents |x pharmacology |v Handbooks | |
650 | 4 | |a Antipsychotic drugs |v Handbooks, manuals, etc | |
650 | 4 | |a Mood Disorders |x drug therapy |v Handbooks | |
650 | 4 | |a Schizophrenia |x Chemotherapy |v Handbooks, manuals, etc | |
650 | 4 | |a Schizophrenia |x drug therapy |v Handbooks | |
856 | 4 | |u http://www.loc.gov/catdir/description/cam022/2002023355.html |3 Publisher description | |
856 | 4 | |u http://www.loc.gov/catdir/toc/cam024/2002023355.html |3 Table of contents | |
856 | 4 | 2 | |m HBZ Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=009869312&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
999 | |a oai:aleph.bib-bvb.de:BVB01-009869312 |
Datensatz im Suchindex
_version_ | 1804129288611430400 |
---|---|
adam_text | Contents
Preface vii
Chapter 1
Psychosis and Schizophrenia 1
Chapter 2
Antipsychotic Agents 37
Suggested Reading 133
Index 137
Continuing Medical Education (CME)
Post Tests and Evaluation
ix
CHAPTER 1
Psychosis and Schizophrenia
I. Clinical description of psychosis
A. Paranoid psychosis
B. Disorganized excited psychosis
C. Depressive psychosis
II. Five symptom dimensions in schizophrenia
A. Positive symptoms
B. Negative symptoms
C. Cognitive symptoms
D. Aggressive and hostile symptoms
E. Depressive and anxious symptoms
HI. Four key dopamine pathways and the biological basis of schizophrenia
A. Mesolimbic dopamine pathway and the dopamine hypothesis of the
positive symptoms of psychosis
B. Mesocortical dopamine pathway
C. Nigrostriatal dopamine pathway
D.Tuberoinfundibular dopamine pathway
IV. Neurodevelopmental hypodieses of schizophrenia
V. Neurodegenerative hypotheses of schizophrenia
A. Excitotoxicity
B. Glutamatergic neurotransmission
VI. Experimental therapeutic approaches
A. Blocking neurodegeneration and apoptosis
B. Presymptomatic treatment
VII. Combined neurodevelopmental neurodegenerative hypothesis
VIII. Summary
CHAPTER 2
Antipsychotic Agents
I. Conventional antipsychotic drugs
A. Blockade of dopamine 2 receptors as the mechanism of action of
conventional antipsychotics
B. The dilemma of blocking D2 dopamine receptors in all four dopamine
pathways
C. Risks and benefits of long term treatment with conventional
antipsychotics
D.Muscarinic cholinergic blocking properties of conventional
antipsychotics
E. Other pharmacologic properties of conventional antipsychotic drugs
II. Atypical antipsychotic drugs: Serotonin dopamine antagonism and what
several antipsychotic drugs have in common
A. Serotonin dopamine antagonism and serotonergic control of dopamine
release in the four key dopamine pathways
B. Serotonin dopamine interactions in the nigrostriatal
C. The nigrostriatal pathway and the pharmacology of low extrapyramidal
symptoms
D. The mesocortical pathway and the pharmacology of improved negative
symptoms
E. The tuberoinfundibular pathway and the pharmacology of reduced
hyperprolactinemia
E The mesolimbic pathway and the pharmacology of improved positive
symptoms
G. Summary of actions of atypical antipsychotics as a class
HI. Atypical antipsychotics: Several unique drugs or one class of several drugs?
A. Clozapine
B. Risperidone
C. Olanzapine
37
38 Essential Psychopharmacology of Antipsychotics and Mood Stabilizers
D. Quetiapine
E. Ziprasidone
IV. Pharmacokinetic considerations for the atypical antipsychotic drugs
A. Cytochrome P450 1A2
B. Cytochrome P450 2D6
C. Cytochrome P450 3A4
V. Atypical antipsychotics in clinical practice
A. Use of atypical antipsychotics for positive symptoms of schizophrenia and
related disorders
B. Use of atypical antipsychotics to treat disorders of mood in schizophrenia
and related disorders
C. Use of atypical antipsychotics for cognitive symptoms of schizophrenia
and related disorders
D.Use of atypical antipsychotics for negative symptoms of schizophrenia
E. Use of atypical antipsychotics for treating hostility, aggression, and poor
impulse control in schizophrenia and related disorders
VI. Novel theories about dopamine 2 receptors and antipsychotic
mechanisms
A. Hit and run actions at dopamine receptors: possible mechanism of
action of atypical antipsychotics
B. Dopamine system stabilizers: The goldilocks antipsychotics
VII. Atypical antipsychotics as mood stabilizers for bipolar disorder
A. Bipolar disorder and a brainstorm of ions
B. Mood stabilizing drugs
VIII. Combining drugs for treatment resistant schizophrenia
DC. Other antipsychotics
X. Future antipsychotics
A. Novel serotonergic and dopaminergic mechanisms
B. Novel neurotransmitter mechanisms other than serotonin and dopamine
for therapeutic strategies in schizophrenia
C. Future combination chemotherapies for schizophrenia and other psychotic
disorders
XI. Summary
|
any_adam_object | 1 |
author | Stahl, Stephen M. 1951- |
author_GND | (DE-588)136518257 |
author_facet | Stahl, Stephen M. 1951- |
author_role | aut |
author_sort | Stahl, Stephen M. 1951- |
author_variant | s m s sm sms |
building | Verbundindex |
bvnumber | BV014438746 |
callnumber-first | R - Medicine |
callnumber-label | RM333 |
callnumber-raw | RM333.5 |
callnumber-search | RM333.5 |
callnumber-sort | RM 3333.5 |
callnumber-subject | RM - Therapeutics and Pharmacology |
ctrlnum | (OCoLC)49376212 (DE-599)BVBBV014438746 |
dewey-full | 615/.788 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 615 - Pharmacology and therapeutics |
dewey-raw | 615/.788 |
dewey-search | 615/.788 |
dewey-sort | 3615 3788 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01810nam a2200445zc 4500</leader><controlfield tag="001">BV014438746</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20020903 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">020603s2002 xxkad|| |||| 00||| eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a">2002023355</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0521890748</subfield><subfield code="9">0-521-89074-8</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)49376212</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV014438746</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxk</subfield><subfield code="c">GB</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-29</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM333.5</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.788</subfield><subfield code="2">21</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Stahl, Stephen M.</subfield><subfield code="d">1951-</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)136518257</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Essential psychopharmacology of antipsychotics and mood stabilizers</subfield><subfield code="c">Stephen M. Stahl</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cambridge</subfield><subfield code="b">Cambridge Univ. Pr.</subfield><subfield code="c">2002</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">IX, 142 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references (p. 133-136) and index</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Antipsychotische geneesmiddelen</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Psychosen</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Schizofrenie</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antipsychotic Agents</subfield><subfield code="x">pharmacology</subfield><subfield code="v">Handbooks</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antipsychotic drugs</subfield><subfield code="v">Handbooks, manuals, etc</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Mood Disorders</subfield><subfield code="x">drug therapy</subfield><subfield code="v">Handbooks</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Schizophrenia</subfield><subfield code="x">Chemotherapy</subfield><subfield code="v">Handbooks, manuals, etc</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Schizophrenia</subfield><subfield code="x">drug therapy</subfield><subfield code="v">Handbooks</subfield></datafield><datafield tag="856" ind1="4" ind2=" "><subfield code="u">http://www.loc.gov/catdir/description/cam022/2002023355.html</subfield><subfield code="3">Publisher description</subfield></datafield><datafield tag="856" ind1="4" ind2=" "><subfield code="u">http://www.loc.gov/catdir/toc/cam024/2002023355.html</subfield><subfield code="3">Table of contents</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=009869312&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-009869312</subfield></datafield></record></collection> |
id | DE-604.BV014438746 |
illustrated | Illustrated |
indexdate | 2024-07-09T19:02:45Z |
institution | BVB |
isbn | 0521890748 |
language | English |
lccn | 2002023355 |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-009869312 |
oclc_num | 49376212 |
open_access_boolean | |
owner | DE-29 |
owner_facet | DE-29 |
physical | IX, 142 S. Ill., graph. Darst. |
publishDate | 2002 |
publishDateSearch | 2002 |
publishDateSort | 2002 |
publisher | Cambridge Univ. Pr. |
record_format | marc |
spelling | Stahl, Stephen M. 1951- Verfasser (DE-588)136518257 aut Essential psychopharmacology of antipsychotics and mood stabilizers Stephen M. Stahl Cambridge Cambridge Univ. Pr. 2002 IX, 142 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Includes bibliographical references (p. 133-136) and index Antipsychotische geneesmiddelen gtt Psychosen gtt Schizofrenie gtt Antipsychotic Agents pharmacology Handbooks Antipsychotic drugs Handbooks, manuals, etc Mood Disorders drug therapy Handbooks Schizophrenia Chemotherapy Handbooks, manuals, etc Schizophrenia drug therapy Handbooks http://www.loc.gov/catdir/description/cam022/2002023355.html Publisher description http://www.loc.gov/catdir/toc/cam024/2002023355.html Table of contents HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=009869312&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
spellingShingle | Stahl, Stephen M. 1951- Essential psychopharmacology of antipsychotics and mood stabilizers Antipsychotische geneesmiddelen gtt Psychosen gtt Schizofrenie gtt Antipsychotic Agents pharmacology Handbooks Antipsychotic drugs Handbooks, manuals, etc Mood Disorders drug therapy Handbooks Schizophrenia Chemotherapy Handbooks, manuals, etc Schizophrenia drug therapy Handbooks |
title | Essential psychopharmacology of antipsychotics and mood stabilizers |
title_auth | Essential psychopharmacology of antipsychotics and mood stabilizers |
title_exact_search | Essential psychopharmacology of antipsychotics and mood stabilizers |
title_full | Essential psychopharmacology of antipsychotics and mood stabilizers Stephen M. Stahl |
title_fullStr | Essential psychopharmacology of antipsychotics and mood stabilizers Stephen M. Stahl |
title_full_unstemmed | Essential psychopharmacology of antipsychotics and mood stabilizers Stephen M. Stahl |
title_short | Essential psychopharmacology of antipsychotics and mood stabilizers |
title_sort | essential psychopharmacology of antipsychotics and mood stabilizers |
topic | Antipsychotische geneesmiddelen gtt Psychosen gtt Schizofrenie gtt Antipsychotic Agents pharmacology Handbooks Antipsychotic drugs Handbooks, manuals, etc Mood Disorders drug therapy Handbooks Schizophrenia Chemotherapy Handbooks, manuals, etc Schizophrenia drug therapy Handbooks |
topic_facet | Antipsychotische geneesmiddelen Psychosen Schizofrenie Antipsychotic Agents pharmacology Handbooks Antipsychotic drugs Handbooks, manuals, etc Mood Disorders drug therapy Handbooks Schizophrenia Chemotherapy Handbooks, manuals, etc Schizophrenia drug therapy Handbooks |
url | http://www.loc.gov/catdir/description/cam022/2002023355.html http://www.loc.gov/catdir/toc/cam024/2002023355.html http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=009869312&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
work_keys_str_mv | AT stahlstephenm essentialpsychopharmacologyofantipsychoticsandmoodstabilizers |